Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11661611 Genetic modification of cytokine inducible SH2-containing protein (CISH) gene

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 31 May, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 31 May, 2023
Edits made to:
Infobox (+38 properties)
Article (+120 characters)
‌

 US Patent 11661611 Genetic modification of cytokine inducible SH2-containing protein (CISH) gene

Article

The present disclosure is in the field of genome engineering, particularly targeted genetic modification of a CISH gene.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Sangamo Therapeutics
Sangamo Therapeutics
0
Current Assignee
Sangamo Therapeutics
Sangamo Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116616110
Date of Patent
May 30, 2023
0
Patent Application Number
161856990
Date Filed
November 9, 2018
0
Patent Citations
‌
US Patent 7153949 Nucleic acid encoding poly-zinc finger proteins with improved linkers
0
‌
US Patent 7163824 Regulation of endogenous gene expression in cells using zinc finger proteins
0
‌
US Patent 7262054 Zinc finger proteins for DNA binding and gene regulation in plants
0
‌
US Patent 7361635 Simultaneous modulation of multiple genes
0
‌
US Patent 7888121 Methods and compositions for targeted cleavage and recombination
0
‌
US Patent 7914796 Engineered cleavage half-domains
0
‌
US Patent 7951925 Methods and compositions for gene inactivation
0
‌
US Patent 8110379 Targeted integration into the PPP1R12C locus
0
‌
US Patent 8153773 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap
0
‌
US Patent 8329986 Targeted integration into the
0
‌
US Patent 8409861 Targeted deletion of cellular DNA sequences
0
‌
US Patent 8563314 Methods and compositions for modulating PD1
0
‌
US Patent 8585526 Vehicle driveline component having heat sink for increased heat rejection capabilities
0
‌
US Patent 8623618 Engineered cleavage half-domains
0
‌
US Patent 8697359 CRISPR-Cas systems and methods for altering expression of gene products
0
‌
US Patent 8703489 Methods and compositions for targeted single-stranded cleavage and targeted integration
0
‌
US Patent 8871905 Modification of CXCR4 using engineered zinc finger proteins
0
‌
US Patent 8936936 Methods and compositions for targeted integration
0
‌
US Patent 8945868 Methods and compositions for modification of a HLA locus
0
‌
US Patent 8956828 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
0
‌
US Patent 9005973 Targeted genomic modification with partially single-stranded donor molecules
0
‌
US Patent 9045763 Linear donor constructs for targeted integration
0
‌
US Patent 9150847 Methods and compositions for regulation of transgene expression
0
‌
US Patent 9200266 Methods and compositions for targeted single-stranded cleavage and targeted integration
0
‌
US Patent 9206404 Method of deleting an IgM gene in an isolated rat cell
0
‌
US Patent 9458205 Modified DNA-binding proteins and uses thereof
0
‌
US Patent 9855298 Methods of conditioning patients for T cell therapy
0
‌
US Patent 9877988 Method of treating lysosomal storage diseases using nucleases and a transgene
0
‌
US Patent 9957526 Delivery methods and compositions for nuclease-mediated genome engineering
0
Patent Primary Examiner
‌
Kagnew H Gebreyesus
0

Find more entities like US Patent 11661611 Genetic modification of cytokine inducible SH2-containing protein (CISH) gene

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo